A detailed history of Deutsche Bank Ag\ transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,546,167 shares of BMRN stock, worth $103 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,546,167
Previous 1,807,032 14.44%
Holding current value
$103 Million
Previous $149 Million 26.95%
% of portfolio
0.05%
Previous 0.07%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$69.02 - $93.84 $18 Million - $24.5 Million
-260,865 Reduced 14.44%
1,546,167 $109 Million
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $39.6 Million - $49.1 Million
-532,204 Reduced 22.75%
1,807,032 $149 Million
Q1 2024

May 15, 2024

SELL
$83.81 - $99.0 $89.1 Million - $105 Million
-1,062,961 Reduced 31.24%
2,339,236 $204 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $153 Million - $197 Million
2,003,478 Added 143.24%
3,402,197 $328 Million
Q3 2023

Nov 09, 2023

SELL
$85.07 - $94.48 $50.7 Million - $56.3 Million
-596,287 Reduced 29.89%
1,398,719 $124 Million
Q2 2023

Aug 14, 2023

SELL
$86.68 - $100.3 $8.82 Million - $10.2 Million
-101,769 Reduced 4.85%
1,995,006 $173 Million
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $25.6 Million - $34.2 Million
-291,991 Reduced 12.22%
2,096,775 $204 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $14.2 Million - $19 Million
175,192 Added 7.91%
2,388,766 $247 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $81.1 Million - $95.7 Million
986,996 Added 80.47%
2,213,574 $188 Million
Q2 2022

Aug 11, 2022

BUY
$71.48 - $86.85 $24 Million - $29.1 Million
335,397 Added 37.64%
1,226,578 $102 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $3.71 Million - $4.63 Million
-49,914 Reduced 5.3%
891,181 $68.7 Million
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $3.46 Million - $4.41 Million
48,216 Added 5.4%
941,095 $83.1 Million
Q3 2021

Nov 04, 2021

SELL
$74.77 - $85.47 $21.2 Million - $24.3 Million
-284,012 Reduced 24.13%
892,879 $69 Million
Q2 2021

Aug 11, 2021

BUY
$75.51 - $84.79 $2.93 Million - $3.29 Million
38,800 Added 3.41%
1,176,891 $98.2 Million
Q1 2021

May 13, 2021

BUY
$74.73 - $90.69 $5.96 Million - $7.23 Million
79,716 Added 7.53%
1,138,091 $85.9 Million
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $22.9 Million - $28.4 Million
-315,173 Reduced 22.95%
1,058,375 $92.8 Million
Q3 2020

Nov 12, 2020

SELL
$71.87 - $131.03 $8.52 Million - $15.5 Million
-118,508 Reduced 7.94%
1,373,548 $104 Million
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $695,505 - $1.09 Million
8,743 Added 0.59%
1,492,056 $184 Million
Q1 2020

May 14, 2020

BUY
$71.37 - $96.85 $13 Million - $17.6 Million
182,136 Added 14.0%
1,483,313 $125 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $5.39 Million - $7.25 Million
83,891 Added 6.89%
1,301,177 $110 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $24.6 Million - $31.1 Million
-365,106 Reduced 23.07%
1,217,286 $82 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $15.2 Million - $17.8 Million
189,620 Added 13.61%
1,582,392 $136 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $41.6 Million - $48.8 Million
494,511 Added 55.05%
1,392,772 $124 Million
Q4 2018

Feb 14, 2019

SELL
$80.14 - $106.07 $26.5 Million - $35.1 Million
-330,575 Reduced 26.9%
898,261 $76.5 Million
Q3 2018

Dec 21, 2021

BUY
$93.92 - $105.72 $22.4 Million - $25.2 Million
238,282 Added 24.06%
1,228,836 $119 Million
Q3 2018

Nov 14, 2018

SELL
$93.92 - $105.72 $12.7 Million - $14.3 Million
-135,536 Reduced 12.04%
990,554 $96 Million
Q2 2018

Apr 21, 2020

BUY
$76.01 - $99.03 $10.8 Million - $14 Million
141,856 Added 14.41%
1,126,090 $106 Million
Q2 2018

Aug 14, 2018

SELL
$76.01 - $99.03 $20 Million - $26.1 Million
-263,715 Reduced 21.13%
984,234 $92.7 Million
Q1 2018

Oct 18, 2019

BUY
$77.67 - $92.63 $11.4 Million - $13.6 Million
146,556 Added 13.31%
1,247,949 $101 Million
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $5.52 Million - $6.59 Million
71,091 Added 6.9%
1,101,393 $89.3 Million
Q4 2017

Feb 14, 2018

SELL
$80.76 - $95.13 $29.2 Million - $34.4 Million
-361,778 Reduced 25.99%
1,030,302 $91.9 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $112 Million - $132 Million
1,392,080
1,392,080 $130 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.